高眼圧症(Ocular Hypertension)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Ocular Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Ocular Hypertension 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Ocular Hypertension 33
May 11, 2015: Promising preclinical data on NCX 667 for glaucoma presented at ARVO by Nicox 33
May 11, 2015: Promising preclinical data on NCX 470 for glaucoma presented at ARVO by Nicox 33
Apr 23, 2015: Aerie Pharmaceuticals Reports Initial Rhopressa Phase 3 Efficacy Results 33
Mar 24, 2015: Aerie Pharmaceuticals Completes Enrollment in Second Phase 3 Registration Trial of Rhopressa, Novel Triple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Actavis plc 43
Clinical Trial Overview of Actavis plc 43
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
Santen Pharmaceutical Co., Ltd. 52
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 52
Aerie Pharmaceuticals, Inc. 55
Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 55
Valeant Pharmaceuticals International, Inc. 57
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 57
Merck & Co., Inc. 59
Clinical Trial Overview of Merck & Co., Inc. 59
QLT Inc. 60
Clinical Trial Overview of QLT Inc. 60
Mati Therapeutics Inc. 61
Clinical Trial Overview of Mati Therapeutics Inc. 61
Kowa Company, Ltd. 62
Clinical Trial Overview of Kowa Company, Ltd. 62
Clinical Trial Overview of Top Institutes / Government 63
Medical University of Vienna 63
Clinical Trial Overview of Medical University of Vienna 63
Aristotle University Of Thessaloniki 64
Clinical Trial Overview of Aristotle University Of Thessaloniki 64
University of Colorado Denver 65
Clinical Trial Overview of University of Colorado Denver 65
University of Sao Paulo 66
Clinical Trial Overview of University of Sao Paulo 66
Association for Research in Supporting System of Chronic Diseases 67
Clinical Trial Overview of Association for Research in Supporting System of Chronic Diseases 67
Department of Health, South Africa 68
Clinical Trial Overview of Department of Health, South Africa 68
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 69
Clinical Trial Overview of IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 69
University Health Network 70
Clinical Trial Overview of University Health Network 70
University of Nebraska 71
Clinical Trial Overview of University of Nebraska 71
University of Parma 72
Clinical Trial Overview of University of Parma 72
Five Key Clinical Profiles 73
Appendix 100
Abbreviations 100
Definitions 100
Research Methodology 101
Secondary Research 101
About GlobalData 102
Contact Us 102
Disclaimer 102
Source 102